Coronary Bioresorbable Scaffolds Nearly as Safe and Effective as Conventional Metal Stents for Heart Disease Patients

First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing percutaneous coronary intervention (PCI).

Stress Testing Can Help Determine Which Patients Are Likely to Benefit From Heart Procedures to Improve Survival

Mount Sinai study can help guide proper treatment course for patients depending on heart function and severity of heart damage